MoneyWorks4Me

FDC - Quaterly Results

07 Feb 2024 Evaluate
The revenue zoomed 11.22% to Rs. 4522.15 millions for the quarter ended December 2023 as compared to Rs. 4066.06 millions during the corresponding quarter last year.Profit for the quarter ended December 2023 rises by 98.77% to Rs. 783.76  millions from Rs. 394.31 millions.OP of the company witnessed a marginal growth to 1072.32 millions from 652.83 millions in the same quarter last year.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202312 202212 % Var 202312 202212 % Var 202303 202203 % Var
Sales 4522.15 4066.06 11.22 14619.53 13458.35 8.63 17770.32 15189.65 16.99
Other Income 253.31 187.63 35.01 825.00 667.93 23.52 539.12 787.34 -31.53
PBIDT 1072.32 652.83 64.26 3631.17 2444.61 48.54 3084.87 3255.80 -5.25
Interest 9.67 11.84 -18.33 30.56 28.91 5.71 40.39 30.48 32.51
PBDT 1062.65 640.99 65.78 3600.61 2415.70 49.05 3044.48 3225.32 -5.61
Depreciation 99.33 98.12 1.23 293.34 290.67 0.92 387.58 370.81 4.52
PBT 963.32 542.87 77.45 3307.27 2125.03 55.63 2656.90 2854.51 -6.92
TAX 179.56 148.56 20.87 717.59 487.77 47.12 647.25 658.15 -1.66
Deferred Tax -24.44 32.56 -175.06 -6.60 -54.23 -87.83 -42.75 -21.85 95.65
PAT 783.76 394.31 98.77 2589.68 1637.26 58.17 2009.65 2196.36 -8.50
Equity 162.81 165.91 -1.87 165.91 165.91 0.00 165.91 168.81 -1.72
PBIDTM(%) 23.71 16.06 47.69 24.84 18.16 36.74 17.36 21.43 -19.01
Peers
Company Name CMP
Sun Pharma. Inds. 1853.50
Dr. Reddys Labs. 1202.80
Cipla 1397.20
Lupin 2090.00
Zydus Lifesciences 1202.00
View more..